Specific anti-gp41 antibodies predict HIV-1 disease progression

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):403-5. doi: 10.1097/QAI.0b013e318264b307.

Abstract

The immunodeficiency-defining AIDS results from a progressive decline of CD4 cell count. We previously showed that 3S, a unique motif of the HIV-1 gp41 envelop protein, is highly conserved in HIV-1 strains and induces expression of NKp44L, rendering CD4 cells sensitive to NK killing. Here we found from a well-characterized cohort of 244 untreated HIV-1 seroconverters that high levels of anti-3S antibodies significantly delay spontaneous disease progression in the first years after seroconversion; this effect was not mediated through baseline viral load or CD4. These results could have important implications both for clinical care and better understanding of pathogenicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • CD4 Lymphocyte Count
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HIV Envelope Protein gp41 / immunology
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV Seropositivity / immunology
  • HIV-1 / immunology*
  • Humans
  • Male
  • Retrospective Studies
  • Viral Load / immunology
  • Young Adult

Substances

  • Antibodies, Viral
  • HIV Envelope Protein gp41